Somatic mosaicism of the PI3K-AKT-MTOR pathway is associated with hemimegalencephaly in fetal brains

被引:2
|
作者
Itoh, Kyoko [1 ]
Pooh, Ritsuko [2 ,3 ]
Shimokawa, Osamu [3 ]
Fushiki, Shinji [1 ]
机构
[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pathol & Appl Neurobiol, Kyoto, Japan
[2] Fetal Brain Ctr, Fetal Diagnost Ctr, CRIFM Prenatal Med Clin, Osaka, Japan
[3] Ritz Med Co Ltd, Clin Lab, Osaka, Japan
关键词
AKT1; hemimegalencephaly; heterotopia; PIK3CA; polymicrogyria; MUTATIONS CAUSE; SPECTRUM; MTOR;
D O I
10.1111/neup.12875
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
It is known that somatic activation of PI3K-AKT-MTOR signaling causes malformations of cortical development varying from hemimegalencephaly to focal cortical dysplasia. However, there have been few reports of fetal cases. Here we report two fetal cases of hemimegalencephaly, one associated with mosaic mutations in PIK3CA and another in AKT1. Both brains showed polymicrogyria, multiple subarachnoidal, subcortical, and subventricular heterotopia resulting from abnormal proliferation of neural stem/progenitor cells, cell differentiation, and migration of neuroblasts. Scattered cell nests immunoreactive for phosphorylated-S6 ribosomal protein (P-RPS6) (Ser240/244) were observed in the polymicrogyria-like cortical plate, intermediate zone, and arachnoid space, suggesting that the PI3K-AKT-MTOR pathway was actually activated in these cells. Pathological analyses could shed light on the mechanisms involved in disrupted brain development in the somatic mosaicism of the PI3K-AKT-MTOR pathway.
引用
收藏
页码:190 / 196
页数:7
相关论文
共 50 条
  • [31] Analysis of mTOR Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K-AKT-mTOR Pathway Inhibitors
    Kong, Yan
    Si, Lu
    Li, Yiqian
    Wu, Xiaowen
    Xu, Xiaowei
    Dai, Jie
    Tang, Huan
    Ma, Meng
    Chi, Zhihong
    Sheng, Xinan
    Cui, Chuanliang
    Guo, Jun
    CLINICAL CANCER RESEARCH, 2016, 22 (04) : 1018 - 1027
  • [32] Screening of PI3K-AKT-mTOR pathway genes in focal cortical dysplasias in a clinical setting
    Accogli, Andrea
    St-Onge, Judith
    Addour, Nassima
    Dudley, Roy
    Farmer, Jean-Pierre
    Atkinson, Jeffrey
    Poulin, Chantal
    Dubeau, Francois
    Lapalme, Joel Lafond
    Rosenblatt, Bernard
    Albrecht, Steffen
    Riviere, Jean-Baptiste
    Srour, Myriam
    NEUROLOGY, 2018, 90
  • [33] The non-canonical nuclear functions of key players of the PI3K-AKT-MTOR pathway
    Gupta, Sakshi
    Kumar, Mukund
    Chaudhuri, Soumi
    Kumar, Arun
    JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (08) : 3181 - 3204
  • [34] Exploiting the therapeutic potential of the PI3K-AKT-mTOR pathway in enriched populations of gynecologic malignancies
    Eskander, Ramez N.
    Tewari, Krishnansu S.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (06) : 847 - 858
  • [35] Isorhamnetin suppresses colon cancer cell growth through the PI3K-Akt-mTOR pathway
    Li, Chuan
    Yang, Xi
    Chen, Cheng
    Cai, Shaoxin
    Hu, Junbo
    MOLECULAR MEDICINE REPORTS, 2014, 9 (03) : 935 - 940
  • [36] Inhibition of the PI3K-Akt-mTOR signaling pathway in T lymphocytes in patients with active tuberculosis
    Zhang, XueXuan
    Huang, TengYi
    Wu, Ying
    Peng, WenGuang
    Xie, HanBin
    Pan, MeiChen
    Zhou, HuanBin
    Cai, BoZhi
    Wu, YingE
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 59 : 110 - 117
  • [37] The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling
    Shorning, Boris Y.
    Dass, Manisha S.
    Smalley, Matthew J.
    Pearson, Helen B.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) : 1 - 47
  • [38] Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer
    Pierobon, Mariaelena
    Ramos, Corinne
    Wong, Shukmei
    Hodge, K. Alex
    Aldrich, Jessica
    Byron, Sara
    Anthony, Stephen P.
    Robert, Nicholas J.
    Northfelt, Donald W.
    Jahanzeb, Mohammad
    Vocila, Linda
    Wulfkuhle, Julia
    Gambara, Guido
    Gallagher, Rosa I.
    Dunetz, Bryant
    Hoke, Nicholas
    Dong, Ting
    Craig, David W.
    Cristofanilli, Massimo
    Leyland-Jones, Brian
    Liotta, Lance A.
    O'Shaughnessy, Joyce A.
    Carpten, John D.
    Petricoin, Emanuel F.
    CLINICAL CANCER RESEARCH, 2017, 23 (16) : 4919 - 4928
  • [39] The PI3K-Akt-mTOR pathway regulates Aβ oligomer induced neuronal cell cycle events
    Bhaskar, Kiran
    Miller, Megan
    Chludzinski, Alexandra
    Herrup, Karl
    Zagorski, Michael
    Lamb, Bruce T.
    MOLECULAR NEURODEGENERATION, 2009, 4
  • [40] The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells
    Nepstad, Ina
    Hatfield, Kimberley Joanne
    Gronningsaeter, Ida Sofie
    Reikvam, Hakon
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (08)